Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
College of Agriculture and Life Sciences, Cornell University, Ithaca, NY 14850.
J Dairy Sci. 2024 Mar;107(3):1620-1629. doi: 10.3168/jds.2023-23541. Epub 2023 Oct 6.
Supplementation of oral Ca via blanket administration of an oral Ca bolus at 0 and 24 h after calving has shown limited success in increasing production and minimizing adverse health events. Recent evidence that reductions in blood Ca at 4 d in milk (DIM) are more closely associated with negative outcomes than hypocalcemia at 0 to 24 h postpartum might explain this lack of Ca bolus efficacy. Therefore, our primary objective was to explore the effect of delayed oral Ca bolus supplementation on milk production, with secondary objectives of exploring the effects on disease incidence and postpartum blood Ca dynamics. We conducted a randomized controlled trial on multiparous Holstein cows (n = 998) from 4 herds in New York. At calving, cows were randomly assigned to 1 of 3 treatment groups: (1) control, no supplemental Ca at or around parturition (CON; n = 343); (2) conventional bolus, an oral Ca bolus containing 43 g of Ca at calving and 24 h later (BOL-C; n = 330); or (3) delayed bolus, an oral Ca bolus containing 43 g of Ca at 48 and 72 h after calving (BOL-D; n = 325). We created generalized linear mixed models to analyze differences in milk yield for the first 10 wk of lactation and serum total Ca (tCa) at 1 and 4 DIM between treatment groups; multivariable Poisson regression models were used to analyze adverse event outcomes (metritis, displaced abomasum, herd removal, or a combination of one or more of the 3) in the first 30 DIM. Milk yield increased by week and was not affected by treatment. However, a treatment by parity group interaction for milk yield showed that BOL-D cows in the third parity produced more milk than third-parity BOL-C or CON cows (BOL-D = 52.0 kg/d, 95% confidence interval [50.6, 53.4] kg/d, BOL-C = 47.9 [46.3, 49.5] kg/d, CON = 49.8 [48.2, 51.2] kg/d). The incidence of adverse health events was similar between treatments (BOL-D = 3.7%, BOL-C = 3.7%, CON = 3.6%). Serum tCa was lower at 1 than 4 DIM, and we detected no difference in tCa between treatment groups. Our findings suggest that delaying oral Ca bolus supplementation has limited influence on blood Ca concentrations but may be beneficial to cohorts of cows as a targeted prophylactic supplement to support milk production.
通过在产后 0 和 24 小时给予口服钙丸进行口服钙的 blanket 管理来补充钙,已显示出在增加产量和最大程度减少不良健康事件方面的有限成功。最近的证据表明,与产后 0 至 24 小时的低钙血症相比,第 4 天牛奶中血钙降低(DIM)与负面结果更密切相关,这可能解释了钙丸疗效不佳的原因。因此,我们的主要目标是探讨延迟口服钙丸补充对产奶量的影响,次要目标是探讨对疾病发病率和产后血钙动态的影响。我们在纽约的 4 个牧场对经产荷斯坦奶牛(n = 998)进行了一项随机对照试验。在分娩时,奶牛被随机分配到 3 个治疗组之一:(1)对照组,分娩时或分娩前后不补充钙(CON;n = 343);(2)常规钙丸组,在分娩时和 24 小时后给予含有 43 克钙的口服钙丸(BOL-C;n = 330);或(3)延迟钙丸组,在产后 48 和 72 小时给予含有 43 克钙的口服钙丸(BOL-D;n = 325)。我们创建了广义线性混合模型来分析产奶量在第一个 10 周和第 1 和 4 天 DIM 时血清总钙(tCa)之间在治疗组之间的差异;使用多变量泊松回归模型分析产后 30 天内的不良事件结局(子宫内膜炎、瘤胃移位、牧场撤离或上述 3 种情况中的一种或多种的组合)。产奶量随周增加,不受治疗影响。然而,产奶量的治疗与胎次组交互作用表明,第三胎次的 BOL-D 奶牛比第三胎次的 BOL-C 或 CON 奶牛产奶量更多(BOL-D = 52.0 kg/d,95%置信区间[50.6,53.4] kg/d,BOL-C = 47.9 [46.3,49.5] kg/d,CON = 49.8 [48.2,51.2] kg/d)。治疗组之间的不良健康事件发生率相似(BOL-D = 3.7%,BOL-C = 3.7%,CON = 3.6%)。血清 tCa 在第 1 天低于第 4 天,并且我们在治疗组之间未检测到 tCa 差异。我们的研究结果表明,延迟口服钙丸补充对血钙浓度的影响有限,但可能对奶牛群体有益,作为支持产奶量的靶向预防性补充剂。